RARE

16.6303.43%
EH

Erik Harris

Executive VP & Chief Commercial Officer

Mr. Erik Harris, MBA, is Independent Director of Rezolute, Inc. from March 25, 2025. Mr. Harris served as Independent Director of Inozyme Pharma, Inc. from October 2024 until July 01, 2025. Mr. Harris has been Executive Vice President and Chief Commercial Officer of Ultragenyx Pharmaceutical Inc. since June 11, 2019. He served as Independent Director at Denali Therapeutics Inc. since February 2022 until 2025. He served as Senior Vice President and Head of North American Commercial Operations at Ultragenyx Pharmaceutical Inc. from July 2017 to June 11, 2019 and led the launches of Crysvita® (burosumab) and Mepsevii® (vestronidase alfa). Prior to joining Ultragenyx in 2017, Mr. Harris spent six years at Crescendo Bioscience, a subsidiary of Myriad Genetics, Inc. Mr. Harris served as the Vice-President of Commercial of Crescendo Bioscience, Inc. and served as its Vice President of Marketing & Sales. Mr. Harris has experience building and leading commercial teams within the healthcare industry. At Crescendo he held various leadership positions, most recently as Vice President of Commercial from June 2014 to June 2017, leading all aspects of marketing, sales, managed care and customer service. At Crescendo Bioscience, he led all aspects of marketing, sales, managed care and customer service. Prior to joining Crescendo Bioscience, Mr. Harris served as Vice President of Pulmonology Marketing at InterMune, Inc. since November 16, 2009 and was its vice president of Marketing. He held positions in the commercial organizations at Elan Pharmaceuticals, Inc., Genentech, Inc. and Bristol-Myers Squibb Company. He has been involved in the launches of Tarceva®, Tysabri® and Vectra-DA®. He held sales and marketing management positions at Genentech, notably as Group Brand Manager for Rituxan and Tarceva. Mr. Harris served as a Senior Director of Marketing & Sales at Elan in Gastroenterology and later he served as Senior Director of Strategic Brand Management for Gastroenterology and Neurology. To begin his professional career, Mr. Harris served as a Lieutenant Commander in Naval Aviation and Congressional Fellow for the United States Navy. Mr. Harris earned his Bachelor of Science in Mathematics at the United States Naval Academy and Masters of Business Administration from The Wharton Business School at the University of Pennsylvania.

Positions